BRL29060A in Posttraumatic Stress Disorder

Trial Profile

BRL29060A in Posttraumatic Stress Disorder

Phase of Trial: Phase III

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Paroxetine (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top